Not Yet Recruiting NA INTERVENTIONAL 2-arm NCT06532409

Comparison of Efficacy of Oral Amoxicillin Versus Intravenous Ceftriaxone

Efficacy of Oral Amoxicillin in Comparison to Intravenous Ceftriaxone in Treatment of Uncomplicated Community Acquired Pneumonia (Cap) Among Children of Age 2-5 Years of Age

Sponsor: RESnTEC, Institute of Research

Conditions Community-acquired Pneumonia

Interventions Amoxicillin/CA IV ceftriaxone

Updated 2 times since 2024 Last updated: Jul 31, 2024 Started: Oct 1, 2024 Primary completion: Sep 30, 2025 Completion: Sep 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06532409, this NA trial focuses on Community-acquired Pneumonia and remains actively recruiting participants. Sponsored by RESnTEC, Institute of Research, it has been updated 2 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

2 versions recorded

Sep 2024 — Present [monthly]

Not Yet Recruiting NA
Aug 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

RESnTEC, Institute of Research

Data source: RESnTEC, Institute of Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lahore, Pakistan